Justin Walsh

Stock Analyst at Jones Trading

(2.97)
# 1,536
Out of 5,044 analysts
37
Total ratings
42.86%
Success rate
12.65%
Average return

Stocks Rated by Justin Walsh

Praxis Precision Medicines
Sep 18, 2025
Initiates: Buy
Price Target: $83
Current: $199.33
Upside: -58.36%
Lantheus Holdings
Sep 16, 2025
Maintains: Buy
Price Target: $109$84
Current: $57.33
Upside: +46.52%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.42
Upside: +606.38%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $3.77
Upside: +218.30%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $9.37
Upside: +220.17%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $79.92
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $5.09
Upside: +116.11%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $13.62
Upside: +32.16%
Rapport Therapeutics
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $28.96
Upside: +45.03%
Perspective Therapeutics
May 16, 2024
Maintains: Buy
Price Target: $15$22
Current: $2.87
Upside: +666.55%
Initiates: Buy
Price Target: $16
Current: $4.92
Upside: +225.53%
Initiates: Buy
Price Target: $20
Current: $4.78
Upside: +318.41%
Reinstates: Buy
Price Target: $4
Current: $0.84
Upside: +378.35%
Initiates: Buy
Price Target: $20
Current: $4.82
Upside: +314.94%
Initiates: Buy
Price Target: $360
Current: $26.93
Upside: +1,237.05%
Initiates: Buy
Price Target: $440
Current: $1.57
Upside: +27,925.48%
Initiates: Buy
Price Target: $75
Current: $0.58
Upside: +12,727.09%
Maintains: Buy
Price Target: $17$20
Current: $38.15
Upside: -47.58%
Maintains: Buy
Price Target: $440$200
Current: $1.50
Upside: +13,233.33%
Initiates: Buy
Price Target: $10
Current: $4.10
Upside: +143.90%